Dr. Venook on the Need for Collaboration in Research

Alan P. Venook, MD
Published: Monday, Oct 14, 2013

Alan P. Venook, MD, a professor in the Department of Medicine (Hematology/Oncology) at the University of California, San Francisco, discusses the need for collaboration in cancer research.

There are a couple of reasons that U.S. physicians attend conferences like the 15th World Congress on Gastrointestinal Cancer, which was held from July 3-6, 2013, in Barcelona, Spain. Venook says that physicians in Europe are leading the field in advances and have a different regulatory environment and different interactions with the pharmaceutical industry.

In addition to learning directly from their European counterparts, U.S. physicians can see results from their studies too. This allows for physicians to work in a uniform way across the oceans, Venook says, in terms of doing research and asking questions that make sense. Venook says that cancer is not discriminatory against people in the U.S., Europe, or Asia, so collaboration is crucial.

Alan P. Venook, MD, a professor in the Department of Medicine (Hematology/Oncology) at the University of California, San Francisco, discusses the need for collaboration in cancer research.

There are a couple of reasons that U.S. physicians attend conferences like the 15th World Congress on Gastrointestinal Cancer, which was held from July 3-6, 2013, in Barcelona, Spain. Venook says that physicians in Europe are leading the field in advances and have a different regulatory environment and different interactions with the pharmaceutical industry.

In addition to learning directly from their European counterparts, U.S. physicians can see results from their studies too. This allows for physicians to work in a uniform way across the oceans, Venook says, in terms of doing research and asking questions that make sense. Venook says that cancer is not discriminatory against people in the U.S., Europe, or Asia, so collaboration is crucial.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions and New Answers to Optimize OutcomesOct 31, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x